Supplementary Figure 5 from Prolongation of Overall Survival in Advanced Lung Adenocarcinoma Patients with the XAGE1 (GAGED2a) Antibody

Yoshihiro Ohue,Koji Kurose,Yu Mizote,Hirofumi Matsumoto,Yumi Nishio,Midori Isobe, Minoru Fukuda,Akiko Uenaka,Mikio Oka,Eiichi Nakayama

crossref（2023）

引用 0|浏览1

暂无评分

摘要

OS of the advanced adenocarcinoma patients with EGFRwt or EGFRmt tumors (A), and with XAGE1 (GAGED2a) antigen-positive EGFRwt or EGFRmt tumors and antibody, and XAGE1 (GAGED2a) antigen-negative EGFRmt tumors (B).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要